These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function. McCarthy JT, Williams AW, Johnson WJ. J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998 [Abstract] [Full Text] [Related]
8. New adsorption column (Lixelle) to eliminate beta2-microglobulin for direct hemoperfusion. Furuyoshi S, Nakatani M, Taman J, Kutsuki H, Takata S, Tani N. Ther Apher; 1998 Feb; 2(1):13-7. PubMed ID: 10227783 [Abstract] [Full Text] [Related]
9. Performance of the newer type (Lixelle Type S-15) on direct hemoperfusion beta-2-microglobulin adsorption column for dialysis-related amyloidosis. Hiyama E, Hyodo T, Kondo M, Otsuka K, Honma T, Taira T, Yoshida K, Uchida T, Endo T, Sakai T, Baba S, Hidai H. Nephron; 2002 Oct; 92(2):501-2. PubMed ID: 12218344 [No Abstract] [Full Text] [Related]
11. Long-term efficacy and safety of the small-sized β2-microglobulin adsorption column for dialysis-related amyloidosis. Yamamoto Y, Hirawa N, Yamaguchi S, Ogawa N, Takeda H, Shibuya K, Kawahara K, Kojima H, Dobashi Y, Fujita M, Azusima K, Miyazaki N, Kobayashi M, Kobayashi C, Fujiwara A, Yuto J, Saka S, Yatsu K, Toya Y, Yasuda G, Ohnishi T, Umemura S. Ther Apher Dial; 2011 Oct; 15(5):466-74. PubMed ID: 21974700 [Abstract] [Full Text] [Related]
12. Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column. Gejyo F, Kawaguchi Y, Hara S, Nakazawa R, Azuma N, Ogawa H, Koda Y, Suzuki M, Kaneda H, Kishimoto H, Oda M, Ei K, Miyazaki R, Maruyama H, Arakawa M, Hara M. Artif Organs; 2004 Apr; 28(4):371-80. PubMed ID: 15084199 [Abstract] [Full Text] [Related]